Edwards Lifesciences Target Price

See Edwards Lifesciences's analyst price targets ($100) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$90.87

Average Target Price

$104.63

15.1% upside

8 analysts in the last 4 months

High: $110 | Low: $95

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-28	UBS	$110	21.1% upside
2026-07-24	Leerink PartnersMike Kratky	$101	11.1% upside
2026-07-24	Piper Sandler	$101	11.1% upside
2026-07-16	Truist FinancialRichard Newitter	$95	4.5% upside
2026-07-13	RBC Capital	$110	21.1% upside
2026-07-06	Evercore ISI	$100	10% upside
2026-06-30	BTIGMarie Thibault	$110	21.1% upside
2026-04-27	Barclays	$110	21.1% upside
2026-04-24	Truist Financial	$90	1% downside
2026-04-24	Canaccord GenuityWilliam Plovanic	$85	6.5% downside
2026-04-24	BTIG	$100	10% upside
2026-04-24	Evercore ISIVijay Kumar	$93	2.3% upside
2026-04-13	Mizuho Securities	$95	4.5% upside
2026-02-11	Goldman SachsDavid Roman	$95	4.5% upside
2026-02-11	Piper Sandler	$100	10% upside
2026-02-11	Truist FinancialRichard Newitter	$89	2.1% downside
2026-02-04	UBSDanielle Antalffy	$94	3.4% upside
2026-01-20	Stifel Nicolaus	$110	21.1% upside
2026-01-20	Piper Sandler	$98	7.8% upside
2026-01-12	Barclays	$104	14.4% upside
2026-01-12	Robert W. Baird	$90	1% downside
2026-01-12	UBSDanielle Antalffy	$95	4.5% upside
2026-01-09	Goldman SachsDavid Roman	$108	18.9% upside
2026-01-07	Stifel NicolausRick Wise	$105	15.5% upside
2026-01-05	Evercore ISI	$94	3.4% upside
2025-12-18	Wells Fargo	$100	10% upside
2025-12-17	Canaccord GenuityWilliam Plovanic	$87	4.3% downside
2025-12-16	Robert W. BairdDavid Rescott	$87	4.3% downside
2025-12-08	Barclays	$103	13.3% upside
2025-12-05	RBC CapitalShagun Singh	$100	10% upside
2025-12-05	Robert W. BairdDavid Rescott	$88	3.2% downside
2025-12-05	Truist FinancialRichard Newitter	$92	1.2% upside
2025-12-05	UBS	$92	1.2% upside
2025-12-05	Stifel NicolausRick Wise	$100	10% upside
2025-12-05	Wells FargoLarry Biegelsen	$96	5.6% upside
2025-12-05	Canaccord GenuityWilliam Plovanic	$89	2.1% downside
2025-12-04	BTIGMarie Thibault	$103	13.3% upside
2025-11-03	BernsteinLee Hambright	$90	1% downside
2025-11-03	Raymond JamesJayson Bedford	$96	5.6% upside
2025-11-03	Canaccord GenuityWilliam Plovanic	$84	7.6% downside
2025-11-03	UBS	$90	1% downside
2025-10-31	Robert W. BairdDavid Rescott	$83	8.7% downside
2025-10-31	RBC Capital	$95	4.5% upside
2025-10-31	Goldman Sachs	$104	14.4% upside
2025-10-31	National Bank	$92	1.2% upside
2025-10-31	Barclays	$99	8.9% upside
2025-10-29	JefferiesMatthew Taylor	$98	7.8% upside
2025-10-28	Truist Financial	$87	4.3% downside
2025-10-27	Truist Financial	$82	9.8% downside
2025-10-07	Evercore ISI	$88	3.2% downside

Edwards Lifesciences (EW) FAQ

The latest target price for EW is $100. Investors often review this figure alongside Edwards Lifesciences's historical trend and sector peers before judging valuation or financial health.

Edwards Lifesciences trades near $90.87 while the consensus target sits at $100 (15.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting EW's target price ($100), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Edwards Lifesciences's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.